The use of blood biomarkers to predict radiation lung toxicity: a potential strategy to individualize thoracic radiation therapy.
about
Complications from Stereotactic Body Radiotherapy for Lung CancerAssociation of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancerPrescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapyTransforming growth factor β-1 (TGF-β1) is a serum biomarker of radiation induced fibrosis in patients treated with intracavitary accelerated partial breast irradiation: preliminary results of a prospective studyMolecular mechanisms and treatment of radiation-induced lung fibrosisThe role of alveolar epithelium in radiation-induced lung injuryThe association between TGF-β1 polymorphisms and radiation pneumonia in lung cancer patients treated with definitive radiotherapy: a meta-analysis.Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.Long-term pulmonary function in survivors of childhood cancerTargeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy.Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cellsTherapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice.How Will Big Data Improve Clinical and Basic Research in Radiation Therapy?Personalized radiotherapy: concepts, biomarkers and trial designSingle-nucleotide polymorphisms of TGFβ1 and ATM associated with radiation-induced pneumonitis: a prospective cohort study of thoracic cancer patients in China.Lipopolysaccharide-binding protein is efficient in biodosimetry during radiotherapy of lung cancerPulmonary outcomes in survivors of childhood cancer: a systematic review.Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other.Radiation pneumonitis after stereotactic radiation therapy for lung cancer.Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.TGF-β1 rs1982073 polymorphism contributes to radiation pneumonitis in lung cancer patients: a meta-analysis.Loss of Nrf2 promotes alveolar type 2 cell loss in irradiated, fibrotic lung.Transforming growth factor-beta-1 is a serum biomarker of radiation-induced pneumonitis in esophageal cancer patients treated with thoracic radiotherapy: preliminary results of a prospective study.Strategies to optimize radiotherapy based on biological responses of tumor and normal tissue.Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition.Blood-based biomarkers for precision medicine in lung cancer: precision radiation therapy.Molecular Mechanisms and Treatment of Radiation-Induced Lung Fibrosis.Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study
P2860
Q26995851-30FF93A3-CDC9-46C6-A384-CDE09E2D1B13Q33699084-DAF23DDB-1A6E-46A5-8D96-2120F7E17251Q33875793-A4E440DC-75E2-4830-8583-DB418367440AQ33924394-BF206FC5-075C-44FB-9143-257E7EE51A0CQ34142102-65A0B86F-890C-4B44-B87D-DF1C38D39A7DQ34551617-A925CB7F-543D-49C7-AB34-2125C7B361A7Q35123851-AD907580-BC91-4234-B2B6-F84C3FB96C5BQ35273018-406D9340-8231-4834-A34D-DCF3A551329DQ35563839-72B397B7-0E3D-4C42-94B5-30D0881F116CQ35583991-0316A8F1-A6BB-470E-B341-356E3AF26D32Q35761391-161B1A34-8172-4AB9-B7C8-728AEE8F1E62Q35787118-F7ECDCE8-9345-44FD-91D4-F32B406705B7Q35900753-4DCD769B-344A-4039-9800-775EE3FDDE73Q36235704-D6761343-7345-44FB-BD86-8A48068FDBBFQ36318005-EAF1EA57-6661-4DB2-A017-19912F0BEAE3Q37287997-2BB4B712-AB6B-4B39-9F99-9AC25BC4B144Q37523788-826D6D49-EEBB-45EE-A658-5483A6C951F2Q37643967-D975DE62-8E9A-4B6E-9063-9942B6B7254CQ38256158-2F9B152B-E128-40B9-B84D-662749C5A731Q38757792-0E1A84B7-9252-4BA1-A8D5-01FE71E89D35Q39548293-55DA7E87-63FE-4754-B89A-3F426D34CCB2Q40502254-FF2C7BBB-61ED-4517-A170-E8527268F291Q41171923-F6544BF2-6A58-453A-A99C-3FE8E4E50DD6Q41984684-FD99427B-215C-462D-81A4-0DB7C45C3C1EQ42947185-AC17A32F-3C22-41BC-85E3-DCEFD9CD5BD6Q47344087-701E4B29-102F-4078-8D04-5758FCFB7111Q55497904-08404DC4-3663-4FA0-BA21-F00BC0FEFF62Q57764566-7CCDCC97-F408-4C57-B945-075FE8C6A6A6
P2860
The use of blood biomarkers to predict radiation lung toxicity: a potential strategy to individualize thoracic radiation therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The use of blood biomarkers to ...... ze thoracic radiation therapy.
@en
The use of blood biomarkers to ...... ze thoracic radiation therapy.
@nl
type
label
The use of blood biomarkers to ...... ze thoracic radiation therapy.
@en
The use of blood biomarkers to ...... ze thoracic radiation therapy.
@nl
prefLabel
The use of blood biomarkers to ...... ze thoracic radiation therapy.
@en
The use of blood biomarkers to ...... ze thoracic radiation therapy.
@nl
P2093
P1433
P1476
The use of blood biomarkers to ...... ze thoracic radiation therapy.
@en
P2093
Feng-Ming Kong
Theodore S Lawrence
Xiaoping Ao
P304
P356
10.1177/107327480801500206
P577
2008-04-01T00:00:00Z